Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications

R Datta, TM Heaster, JT Sharick… - … of biomedical optics, 2020 - spiedigitallibrary.org
Significance: Fluorescence lifetime imaging microscopy (FLIM) is a powerful technique to
distinguish the unique molecular environment of fluorophores. FLIM measures the time a …

[HTML][HTML] Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

GE Wensink, SG Elias, J Mullenders… - NPJ precision …, 2021 - nature.com
Effective predictive biomarkers are needed to enable personalized medicine and increase
treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and …

Tumor microenvironment in glioblastoma: Current and emerging concepts

P Sharma, A Aaroe, J Liang… - Neuro-Oncology …, 2023 - academic.oup.com
Glioblastoma (GBM) tumor microenvironment (TME) is a highly heterogeneous and complex
system, which in addition to cancer cells, consists of various resident brain and immune cells …

[HTML][HTML] Promises and challenges of organoid-guided precision medicine

S Bose, H Clevers, X Shen - Med, 2021 - cell.com
Organoids are self-organizing, expanding 3D cultures derived from stem cells. Using tissue
derived from patients, these miniaturized models recapitulate various aspects of patient …

Label-free sensing of cells with fluorescence lifetime imaging: The quest for metabolic heterogeneity

EA Shirshin, MV Shirmanova… - Proceedings of the …, 2022 - National Acad Sciences
Molecular, morphological, and physiological heterogeneity is the inherent property of cells
which governs differences in their response to external influence. Tumor cell metabolic …

[HTML][HTML] Promising applications of tumor spheroids and organoids for personalized medicine

Z Gilazieva, A Ponomarev, C Rutland, A Rizvanov… - Cancers, 2020 - mdpi.com
Simple Summary Presently, the investigation of the tumor is carried out using different
models. One of the promising areas is the creation of 3D tumor models, such as spheroids …

[HTML][HTML] Patient-derived cancer organoids as predictors of treatment response

M Verduin, A Hoeben, D De Ruysscher… - Frontiers in oncology, 2021 - frontiersin.org
Patient-derived cancer organoids have taken a prominent role in pre-clinical and
translational research and have been generated for most common solid tumors. Cancer …

[HTML][HTML] Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis

T Zhou, Y Xie, X Hou, W Bai, X Li, Z Liu, Q Man… - Journal of Experimental …, 2023 - Springer
Background Chemoresistance is the main reason for the poor prognosis of pancreatic ductal
adenocarcinoma (PDAC). Thus, there is an urgent need to screen out new targets and …

Precision medicine in pancreatic cancer: patient-derived organoid pharmacotyping is a predictive biomarker of clinical treatment response

TT Seppälä, JW Zimmerman, R Suri, H Zlomke… - Clinical Cancer …, 2022 - AACR
Purpose: Patient-derived organoids (PDO) are a promising technology to support precision
medicine initiatives for patients with pancreatic ductal adenocarcinoma (PDAC). PDOs may …

[HTML][HTML] Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3D in vitro cancer models in the drug …

EM Tosca, D Ronchi, D Facciolo, P Magni - Biomedicines, 2023 - mdpi.com
In the last decades three-dimensional (3D) in vitro cancer models have been proposed as a
bridge between bidimensional (2D) cell cultures and in vivo animal models, the gold …